Thioredoxin

PX 12 inhibits hypoxia-induced HIF-1a transcriptional activity (IC50 11 nM) and proliferation of HT29 and MCF-7 tumor cells (IC50 1.9 and 0.9 uM, respectively).

CCF642 is a novel PDI-inhibiting compound with antimyeloma activity.